Professor Hubert Hondermarck
-
Professor
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing - Focus area: Medical Biochemistry
News
News • 9 Jun 2023
Symposium spurs race to beat brain cancer
Experts from across the nation are tackling brain cancer head on with collaboration front and centre following the inaugural symposium of the University of Newcastle’s Mark Hughes Foundation Centre for Brain Cancer Research.
News • 7 Mar 2019
Mark Hughes Foundation awards innovation in brain cancer
Five highly innovative brain cancer research projects have received over $725,000 in funding from the Mark Hughes Foundation (MHF) following a nationwide call-out and scientific review by experts in the field.
News • 31 Jan 2025
Three Tour de Cure Grants awarded
We’re delighted to announce that three researchers in the Mark Hughes Foundation Centre for Brain Cancer Research have been awarded funding in the 2024/2025 Tour de Cure grant round.
News • 27 Mar 2017
Study strikes a nerve with the spread of cancer
A group led by University of Newcastle biochemistry researcher Hubert Hondermarck has found parallels between tissue regeneration, nerve growth and tumour development, confirming for the first time that the nervous system is strongly implicated in the onset and spread of cancer.
News • 18 Dec 2019
NHMRC awards $9.3 million to 13 University of Newcastle projects
The University of Newcastle has received more than $9.3 million in funding to support projects aiming to solve some of the world’s most critical health problems and improve the lives of millions of Australians.
News • 16 Apr 2020
Drug repurposing potential for COVID-19
The COVID-19 pandemic has highlighted the need for anti-viral therapies to treat respiratory virus infections. With a vaccine probably at least 12 months away, drug repurposing (using clinically approved drugs which also have anti-viral activity) offers hope in fast-tracking therapies to possibly treat infected people and save lives.
News • 15 Mar 2019
Research underway to improve prostate cancer diagnosis
Early research findings have indicated that a simple blood test may provide a more accurate way of identifying aggressive prostate cancers, which could result in more immediate treatment for men with high-risk disease and reduce unnecessary procedures for men with benign or low-risk tumours.
News • 15 Dec 2022
Spinal cord pain to PTSD: $5.2m in NHMRC grants to target pressing medical conditions
Both the body and the mind will be a key focus for innovative researchers from the University of Newcastle, who were successful in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.
News • 11 Apr 2025
New funding for targeted therapy in glioblastoma
Professor Hubert Hondermarck has been awarded Cancer Council funding of $439,533 for a translational research project to develop a targeted therapy to treat glioblastoma (GBM) – a deadly form of brain cancer with no effective treatments.
The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.